| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/26/2009 | CN100531737C Huangyangning dispersion tablets and preparation process |
| 08/26/2009 | CN100531735C Novel technique of preparing lactic acid ciprofloxacin injection |
| 08/26/2009 | CN100531734C Atracurium freezing-dried composition |
| 08/26/2009 | CN100531733C Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline |
| 08/26/2009 | CN100531730C Nateglinide-containing hydrophilic pharmaceutical preparation |
| 08/26/2009 | CN100531726C Application of paeonol for preventing and treating fatty liver disease |
| 08/26/2009 | CN100531724C Film preparation for biphasic release of pharmacologically active or other substances |
| 08/26/2009 | CN100531723C Calf serum protein-removing extract for injection and its preparation method |
| 08/26/2009 | CN100531722C Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them |
| 08/26/2009 | CN100531721C Dysmenorrhea treating solid medicine preparation and its preparation process |
| 08/26/2009 | CN100531720C A long-circulating nanoliposome carrier of hydroxycamptothecine and preparation method thereof |
| 08/26/2009 | CN100531719C Slow-released injection containing methotrexate synergist |
| 08/26/2009 | CN100531718C Slow-released injection containing methotrexate synergist |
| 08/26/2009 | CN100531717C Slow-released anticancer preparation containing methotrexate |
| 08/26/2009 | CN100531716C Slow-released injection containing methotrexate and its synergist |
| 08/26/2009 | CN100531715C Slow-released methotrexate injection |
| 08/26/2009 | CN100531714C Preparing method of concentrated Shuanghuanglian oral liquid |
| 08/26/2009 | CN100531713C Ginseng and aconite high concentration injection liquid for treating qi vacuity and yang desertion and its preparation method |
| 08/26/2009 | CN100531712C Dasatini sustained-release implants for treating entity tumor |
| 08/26/2009 | CN100531711C Erlotinib sustained-release implants for treating entity tumor |
| 08/26/2009 | CN100531710C Alendronate pharmaceutical composition and its preparation technique |
| 08/26/2009 | CN100531709C Method for preparing gel for cold of children |
| 08/26/2009 | CN100531686C Artificial foot with adjustable performance and reinforced vertical load-carrying/absorbing capacity |
| 08/25/2009 | USRE40882 High concentration of alpha, beta or gamma interferon in buffered solution with polyvinylpyrrolidone and/or polyethylene oxide, and antioxidant, Trilon B (disodium salt of ethylenediaminetetraacetic acid); bioavailability; topical administration to mucous membrane with prolonged contact; bioavailability |
| 08/25/2009 | US7579377 Use of adapalene or salt thereof to treat skin disorders having an inflammatory or proliferative component such as acne or psoriasis; dosage forms |
| 08/25/2009 | US7579358 Scopine 2,2-diphenylpropionate-metho halides and other salts: propellant-free solution with ethanol and water and an acid; optimum nebulization; storage stability; nebulizer |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579333 for the treatment of osteoporosis, metastatic bone disease, or Paget's disease; reduce ulcerative side effect; dosage forms |
| 08/25/2009 | US7579330 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 08/25/2009 | US7579321 Incotinence therapy controlling dosage |
| 08/25/2009 | US7579189 Aligned scaffolds for improved myocardial regeneration |
| 08/25/2009 | US7579173 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same |
| 08/25/2009 | US7579021 Matrix controlled diffusion drug delivery system comprising therapeutically effective amount of pharmaceutically active agents entrapped in a polymerization product comprising silicon-containing cationic monomers endcapped with acrylic groups; sized and configured for back of eye drug delivery |
| 08/25/2009 | US7579020 Controlled release arginine α-ketoglutarate |
| 08/25/2009 | US7579019 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 08/25/2009 | US7579017 Polysaccharide comprising xanthan gum, alginate, starch, carrageenan and natural gums; surfactant, cosolvent, and diluent; micelle in colloid suspension; plant growth regulators; decreasing fungus and insect infestation |
| 08/25/2009 | US7579014 Mesoporous compositions for use in drug delivery |
| 08/25/2009 | US7579013 Transdermal drug delivery device having stratum corneum-piercing microprojections; pH stability and solubility when dried; |
| 08/25/2009 | US7579010 Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin |
| 08/25/2009 | US7578951 Method of making microcapsules utilizing a fluid ejector |
| 08/25/2009 | US7578852 Prosthetic foot with tunable performance and improved vertical load/shock absorption |
| 08/25/2009 | US7578809 Surface modified viscoelastics for ocular surgery |
| 08/25/2009 | CA2634663C Novel albumin-free factor viii formulations |
| 08/25/2009 | CA2488976C Inhalable epinephrine |
| 08/25/2009 | CA2460710C Pet food product and method of manufacture |
| 08/25/2009 | CA2426936C Oral preparation containing seaweed for reduction of plaque and calculus |
| 08/25/2009 | CA2426680C Process for formulation of antibiotic compounds |
| 08/25/2009 | CA2402708C Torasemide-containing pharmaceutical preparations |
| 08/25/2009 | CA2394794C Methods for preparing pharmaceutical formulations |
| 08/25/2009 | CA2388163C Process for formulation of carbapenem antibiotic compositions |
| 08/25/2009 | CA2368356C Patches containing buprenorphine hydrochloride |
| 08/24/2009 | CA2598095A1 Method of relieving or avoiding side effect of steroid |
| 08/20/2009 | WO2009103069A1 Skin penetration enhancing systems for polar drugs |
| 08/20/2009 | WO2009103035A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | WO2009102944A2 Transdermal micro-patch |
| 08/20/2009 | WO2009102830A1 Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
| 08/20/2009 | WO2009102814A2 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis |
| 08/20/2009 | WO2009102691A1 Wettable fillers for improved release of hydrophilic materials from chewing gum compositions |
| 08/20/2009 | WO2009102487A2 Gas based wound and tissue therapeutics |
| 08/20/2009 | WO2009102467A2 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | WO2009102443A2 Octanoic acid formulations and methods of treatment using the same |
| 08/20/2009 | WO2009102355A2 Adhesive patch systems and methods |
| 08/20/2009 | WO2009102172A2 Pharmaceutical formulation containing choline alfoscerate |
| 08/20/2009 | WO2009102121A2 Solid lipid nanoparticles for drug delivery, a production method therefor, and an injectable preparation comprising the nanoparticles |
| 08/20/2009 | WO2009102038A1 Orally disintegrating tablets |
| 08/20/2009 | WO2009102024A1 Foaming solid preparation for washing oral cavity |
| 08/20/2009 | WO2009101967A1 Phosphatidylserine complex and method for stabilization of phosphatidylserine |
| 08/20/2009 | WO2009101940A1 Tablet having improved elution properties |
| 08/20/2009 | WO2009101658A1 Timed-release pharmaceutical preparation |
| 08/20/2009 | WO2009101657A1 Timed-release pharmaceutical preparation |
| 08/20/2009 | WO2009101656A1 Delayed release preparation |
| 08/20/2009 | WO2009101614A1 Casein particles encapsulating therapeutically active agents and uses thereof |
| 08/20/2009 | WO2009101613A1 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 08/20/2009 | WO2009101467A1 Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease |
| 08/20/2009 | WO2009101412A1 Topical pharmaceutical composition |
| 08/20/2009 | WO2009101320A2 Fine powder of polyamide from renewable materials and method for making such powder |
| 08/20/2009 | WO2009101258A1 Novel pharmaceutical formulation |
| 08/20/2009 | WO2009101210A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101194A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101182A1 Use of etonogestrel for benign prostate hyperplasia (bph). |
| 08/20/2009 | WO2009101165A1 Composition for absorption through mucous tissue |
| 08/20/2009 | WO2009101110A2 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 08/20/2009 | WO2009101021A2 Estradiol-containing drug delivery system |
| 08/20/2009 | WO2009100970A1 Administration form containing preparations made of solanum melongena and cynara scolymus |
| 08/20/2009 | WO2009100886A2 Formulations of flibanserin |
| 08/20/2009 | WO2009100871A2 Drug delivery system with stabilising effect |
| 08/20/2009 | WO2009100716A2 Implantable products comprising nanoparticles |
| 08/20/2009 | WO2009100645A1 Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 08/20/2009 | WO2009100591A1 Use of hydrochloric acid for the manufacture of medicine in treating vascular disease |
| 08/20/2009 | WO2009100587A1 A drug composition for treatment and prevention of ischemic stroke and its preparation methods |
| 08/20/2009 | WO2009080934A3 Allergen desensitization method |
| 08/20/2009 | WO2009066181A3 Oral delayed-release duloxentine hydrochloride pellets |
| 08/20/2009 | WO2009059219A3 Method of engineering polar drug particles with surface-trapped hydrofluoroalkane-philes |
| 08/20/2009 | WO2009040373A3 Galenical formulations of aliskiren |
| 08/20/2009 | WO2009031039A3 Tablet coatings made from modified carboxymethylcellulose materials |
| 08/20/2009 | WO2009003463A3 Use of deuterium oxide for treating virus-based skin diseases |
| 08/20/2009 | WO2008129468A3 Pharmaceutical compositions of clopidogrel |
| 08/20/2009 | WO2008129465A3 Stable pharmaceutical compositions of bupropion |
| 08/20/2009 | WO2008023277A8 Compositions containing coenzyme q-10 and dihydrolipoic acid |
| 08/20/2009 | WO2007099559A9 Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use |